1052 related articles for article (PubMed ID: 34385613)
21. Surprise dip in UK COVID cases baffles researchers.
Ball P
Nature; 2021 Aug; 596(7871):175-176. PubMed ID: 34345038
[No Abstract] [Full Text] [Related]
22. Molecular deconvolution of the neutralizing antibodies induced by an inactivated SARS-CoV-2 virus vaccine.
Zhou X; Wang H; Ji Q; Du M; Liang Y; Li H; Li F; Shang H; Zhu X; Wang W; Jiang L; Stepanov AV; Ma T; Gong N; Jia X; Gabibov AG; Lou Z; Lu Y; Guo Y; Zhang H; Yang X
Protein Cell; 2021 Oct; 12(10):818-823. PubMed ID: 33909239
[No Abstract] [Full Text] [Related]
23. Vaccine against SARS-CoV-2 in previously infected health care workers.
Parisi SG
EBioMedicine; 2021 Sep; 71():103556. PubMed ID: 34454402
[No Abstract] [Full Text] [Related]
24. Modeling the Transmission of the SARS-CoV-2 Delta Variant in a Partially Vaccinated Population.
Avila-Ponce de León U; Avila-Vales E; Huang K
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062363
[TBL] [Abstract][Full Text] [Related]
25. Why Oxford's positive COVID vaccine results are puzzling scientists.
Callaway E
Nature; 2020 Dec; 588(7836):16-18. PubMed ID: 33230278
[No Abstract] [Full Text] [Related]
26. UK science advisers: publish evidence behind COVID vaccine changes.
Nature; 2021 Jan; 589(7841):169-170. PubMed ID: 33437064
[No Abstract] [Full Text] [Related]
27. Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine.
Levine-Tiefenbrun M; Yelin I; Katz R; Herzel E; Golan Z; Schreiber L; Wolf T; Nadler V; Ben-Tov A; Kuint J; Gazit S; Patalon T; Chodick G; Kishony R
Nat Med; 2021 May; 27(5):790-792. PubMed ID: 33782619
[TBL] [Abstract][Full Text] [Related]
28. [Vaccination against SARS-CoV-2 in patients with multiple sclerosis].
Costa Frossard-França L; García-Domínguez JM; Moreno-Torres I; Fortún J; Villar LM; Meca-Lallana V
Rev Neurol; 2021 Apr; 72(7):250-260. PubMed ID: 33764494
[TBL] [Abstract][Full Text] [Related]
29. India's COVID crisis flags need to forecast variants.
Agrawal A
Nature; 2021 Jun; 594(7861):9. PubMed ID: 34075247
[No Abstract] [Full Text] [Related]
30. Want to track pandemic variants faster? Fix the bioinformatics bottleneck.
Hodcroft EB; De Maio N; Lanfear R; MacCannell DR; Minh BQ; Schmidt HA; Stamatakis A; Goldman N; Dessimoz C
Nature; 2021 Mar; 591(7848):30-33. PubMed ID: 33649511
[No Abstract] [Full Text] [Related]
31. COVID vaccines and breastfeeding: what the data say.
Hall S
Nature; 2021 Jun; 594(7864):492-494. PubMed ID: 34163051
[No Abstract] [Full Text] [Related]
32. How can countries stretch COVID vaccine supplies? Scientists are divided over dosing strategies.
Ledford H
Nature; 2021 Jan; 589(7841):182. PubMed ID: 33437062
[No Abstract] [Full Text] [Related]
33. COVID vaccine makers brace for a variant worse than Delta.
Waltz E
Nature; 2021 Oct; 598(7882):552-553. PubMed ID: 34671153
[No Abstract] [Full Text] [Related]
34. Potential sources, modes of transmission and effectiveness of prevention measures against SARS-CoV-2.
Kampf G; Brüggemann Y; Kaba HEJ; Steinmann J; Pfaender S; Scheithauer S; Steinmann E
J Hosp Infect; 2020 Dec; 106(4):678-697. PubMed ID: 32956786
[TBL] [Abstract][Full Text] [Related]
35. India's COVID-vaccine woes - by the numbers.
Padma TV
Nature; 2021 Apr; 592(7855):500-501. PubMed ID: 33854229
[No Abstract] [Full Text] [Related]
36. What scientists do and don't know about the Oxford-AstraZeneca COVID vaccine.
Mallapaty S; Callaway E
Nature; 2021 Apr; 592(7852):15-17. PubMed ID: 33762708
[No Abstract] [Full Text] [Related]
37. Evolving threat.
Kupferschmidt K
Science; 2021 Aug; 373(6557):844-849. PubMed ID: 34413220
[No Abstract] [Full Text] [Related]
38. Omicron's feeble attack on the lungs could make it less dangerous.
Kozlov M
Nature; 2022 Jan; 601(7892):177. PubMed ID: 34987210
[No Abstract] [Full Text] [Related]
39. Response to: COVID-19 re-infection. Vaccinated individuals as a potential source of transmission.
Schiavone M; Gasperetti A; Mitacchione G; Viecca M; Forleo GB
Eur J Clin Invest; 2021 Jun; 51(6):e13544. PubMed ID: 33725359
[No Abstract] [Full Text] [Related]
40. Achieving global equity for COVID-19 vaccines: Stronger international partnerships and greater advocacy and solidarity are needed.
Figueroa JP; Hotez PJ; Batista C; Ben Amor Y; Ergonul O; Gilbert S; Gursel M; Hassanain M; Kang G; Kaslow DC; Kim JH; Lall B; Larson H; Naniche D; Sheahan T; Shoham S; Wilder-Smith A; Sow SO; Strub-Wourgaft N; Yadav P; Bottazzi ME
PLoS Med; 2021 Sep; 18(9):e1003772. PubMed ID: 34516558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
